Bromide

Bromide

SCHEMBL2820333

Br.O=c1ccc2cccnc2[nH]1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.51
AXL P30530 1/20 0.48
NUDT1 P36639 1/20 0.48
CA12 O43570 4/20 0.45
CA9 Q16790 4/20 0.45
CA1 P00915 1/20 0.45
CA3 P07451 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
AURKA O14965 1/20 0.43
PARP1 P09874 1/20 0.43
KDM4E B2RXH2 1/20 0.41
GMNN O75496 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126973 0.98 DAO (0.53) DAOAXLNUDT1CA12CA9
SCHEMBL29498319 0.98 DAO (0.53) DAOAXLNUDT1CA12CA9
Fluoride SCHEMBL28140380 0.96 DAO (0.51) DAOAXLNUDT1CA12CA9
SCHEMBL30213497 0.96 DAO (0.51) DAOAXLNUDT1CA12CA9
Charcoal, Activated SCHEMBL7531966 0.96 DAO (0.51) DAOAXLNUDT1CA12CA9
Hydrochloric Acid SCHEMBL7181738 0.96 DAO (0.51) DAOAXLNUDT1CA12CA9
Hydrochloric Acid SCHEMBL29691659 0.96 DAO (0.51) DAOAXLNUDT1CA12CA9
SCHEMBL4516259 0.91 DAO (0.51) DAOAXLNUDT1CA12CA9
Phosphoric Acid SCHEMBL31544068 0.89 DAO (0.50) DAOAXLNUDT1CA12CA9
Phosphoric Acid SCHEMBL29264269 0.89 DAO (0.50) DAOAXLNUDT1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041145-B1 AZATRICYCLIC COMPOUNDS AND THEIR USE GLAXO GROUP LTD (GB) 2010-10-27 EP disclosed
US-20100004230-A1 AZATRICYCLIC COMPOUNDS AND THEIR USE GLAXO GROUP LIMITED (GB) 2010-01-07 US disclosed
EP-2041145-A1 AZATRICYCLIC COMPOUNDS AND THEIR USE Glaxo Group Limited (GB) 2009-04-01 EP disclosed
WO-2008003690-A1 AZATRICYCLIC COMPOUNDS AND THEIR USE GLAXO GROUP LIMITED (GB) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004230-A1 AZATRICYCLIC COMPOUNDS AND THEIR USE AADAC, AZI2, NNMT DAO 397/4885AXL 3907/4885NUDT1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.